Program
Sunday, October 6
Monday, October 7
- Introduction to Cancer Medicine and Diagnostics
- How to Identify and Develop the Translational Value of Your Research
- Communicating the Translational Value of Your Research
- Proposal Development: Individual Revision and Writing Time
Tuesday, October 8
- Environment of Clinical Investigations
- Entrepreneurship Panel
- Special Seminar and Group Discussion: Unleashing the Power of Immune System -Translational Immunology
- Proposal Development Groups – Meeting #1
WEdnesday, October 9
- How Treatment Decisions Are Made
- Proposal Development Group – Meeting #2
- Clinician/Patient Evening: Small Group Meetings
Thursday, October 10
- From Discovery and Translation to Clinical Application
- Collaborating Effectively with Data Scientists
- Understanding the Role and Impact of Patients: Patient-partnered Cancer Research
- Translating Differently: Innovative and Emerging Approaches
- Post-Test, and Overall Evaluation
Sunday, October 6
REGISTRATION
2:30-3:30 P.M.
Pre-Test
3:30-4 P.m.
Welcome and Introduction from the Course Directors
4-4:30 p.m.
- Ryan B. Corcoran, Massachusetts General Hospital, Boston, Massachusetts
- George D. Demetri, Dana-Farber Cancer Institute, Boston, Massachusetts
- Elaine R. Mardis, The Institute for Genomic Medicine at Nationwide Children’s Hospital, Columbus, Ohio
Keynote Presentation
4:30-5:30 p.m.
Participant Introductions
5:30-6 p.m.
Group Dinner
6-7:30 p.m.
Monday, October 7
BREAKFAST
8-9 a.m.
Introduction to Cancer Medicine and Diagnostics
9-10:45 a.m.
- Overview: An introduction to clinical cancer medicine
George D. Demetri, Dana-Farber Cancer Institute, Boston, Massachusetts - Overview of pathology and molecular tools in diagnostics
Lynette M. Sholl, Brigham and Women’s Hospital, Boston, Massachusetts - Additional speaker to be announced
Group Photo and Coffee Break
10:45-11:30 a.m.
How to Identify and Develop the Translational Value of Your Research
11:30 a.m. – 12:30 p.m.
- Cigall Kadoch, Dana-Farber Cancer Institute, Boston, Massachusetts
Group Lunch with Mentor Tables
12:30-2 p.m.
Communicating the Translational Value of Your Research
2-3:30 P.m.
- Pratiti Bandopadhayay, Dana-Farber Cancer Institute, Boston, Massachusetts
- Additional speaker to be announced
Break
3:30-4 p.m.
Proposal Development Exercise: Orientation and Expectations
4-4:30 p.m.
- Ryan B. Corcoran, Massachusetts General Hospital, Boston, Massachusetts
- George D. Demetri, Dana-Farber Cancer Institute, Boston, Massachusetts
- Elaine R. Mardis, The Institute for Genomic Medicine at Nationwide Children’s Hospital, Columbus, Ohio
Proposal Development: Individual Revision and Writing Time
4:30-6:30 p.m.
Group Dinner
6:30-8 p.m.
Tuesday, October 8
BREAKFAST
8-9 a.m.
Environment of Clinical Investigations
9-11 a.m.
- Protection of human research participants
Carolyn Chapman, Brigham and Women’s Hospital, Boston, Massachusetts - Why quantitative reasoning is important in translational cancer research
Giovanni Parmigiani, Dana-Farber Cancer Institute, Boston, Massachusetts - Additional speakers to be announced
Break
11-11:30 a.m.
Entrepreneurship Panel
11:30 a.m.- 12:30 p.m.
Session Chair: Melissa N. McCracken, Nextech Invest Ltd., Newton, Massachusetts
- Melissa N. McCracken, Nextech Invest Ltd., Newton, Massachusetts
- Additional panelists to be announced
Group Lunch with Mentoring Tables
12:30-2 p.m.
Special Seminar and Group Discussion: Unleashing the Power of Immune System -Translational Immunology
2-3:30 p.m.
- Carl H. June, Perelman School of Med. Univ. of Pennsylvania, Philadelphia, Pennsylvania
- Stephan A. Grupp, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Proposal Development Groups – Meeting #1
3:30-5 p.m.
Mentors:
- Jesse S. Boehm, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts
- Erica K. Evans, MoMa Therapeutics, Cambridge, Massachusetts
- Additional mentors to be announced
Dinner on Own/Free Time
5 p.m.
Wednesday, October 9
BREAKFAST
7:15-8:15 a.m.
Off-Site Patient Clinic Visits
8:15-12 p.m.
Offsite Clinical Visits: Debrief and Discussion
1:30-2:00 p.m.
- Ryan B. Corcoran, Massachusetts General Hospital, Boston, Massachusetts
- George D. Demetri, Dana-Farber Cancer Institute, Boston, Massachusetts
How Treatment Decisions Are Made
2-3:30 p.m.
- Ryan B. Corcoran, Massachusetts General Hospital, Boston, Massachusetts
- George D. Demetri, Dana-Farber Cancer Institute, Boston, Massachusetts
- Adrian Mariño-Enriquez, University College Dublin, Dublin, Ireland
Proposal Development Group – Meeting #2
3:30-5 p.m.
Mentors
- Ryan B. Corcoran, Massachusetts General Hospital, Boston, Massachusetts
- George D. Demetri, Dana-Farber Cancer Institute, Boston, Massachusetts
- Adrian Mariño-Enriquez, University College Dublin, Dublin, Ireland
Group Dinner
5-6:30 p.m.
Clinician/Patient Evening: Small Group Meetings
6:30-8 p.m.
Each small group consists of a clinician, a patient, and approximately 10-15 workshop attendees. This provides a comfortable environment and encourages interaction. We ask doctors to share their perspectives as clinicians and researchers, and patients to speak about whatever they feel most comfortable sharing regarding their experiences as patients/clinical trial participants.
Thursday, October 10
BREAKFAST
8-9 a.m.
From Discovery and Translation to Clinical Application
9:00-10:30 a.m.
- Accelerating prediction of tumor vulnerabilities using precision functional genomics
Jesse S. Boehm, Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts - Additional speaker to be announced
BReak
10:30-11:00 a.m.
Collaborating Effectively with Data Scientists
11:00 a.m.-12:00 p.m.
- Eliezer Van Allen, Dana-Farber Cancer Institute, Boston, Massachusetts
Understanding the Role and Impact of Patients: Patient-partnered Cancer Research
1:30 – 3:00 p.m.
- Corrie Painter, Precede Biosciences, Boston, Massachusetts
- Julie Krause, Fight Colorectal Cancer, Crystal Lake, Illinois
- Connecting researchers and patients: Practical first steps
Bob Riter, Cornell University, Ithaca, New York - Patient involvement in cancer research at UNC Lineberger Comprehensive Cancer Center
Patricia Spears, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Coffee Break/Networking and Individual Questions with the Panelists
3:00-3:30 p.m
Translating Differently: Innovative and Emerging Approaches
3:30-4:30 p.m.
- Joshua D. Schiffman, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah
Closing Remarks
4:30-4:45 p.m.
- Ryan B. Corcoran, Massachusetts General Hospital, Boston, Massachusetts
- George D. Demetri, Dana-Farber Cancer Institute, Boston, Massachusetts
- Elaine R. Mardis, The Institute for Genomic Medicine at Nationwide Children’s Hospital, Columbus, Ohio
Post-Test, and Overall Evaluation
4:45-5:45 p.m.
Closing Dinner
6:00 – 7:30 p.m.
Friday, October 11